Navamedic ASA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Navamedic ASA generated cash of $2,179,000, which is less than the previous year. Cash used in financing activities reached the amount of $83,235,000 last year. Net change in cash is therefore -$17,260,000.
Cash Flow
| 2014 | -10.74M | -887.54K | 15.40M |
|---|---|---|---|
| 2015 | 22.62M | -24.32M | 8.34M |
| 2016 | -14.50M | -1.67M | 31.90M |
| 2017 | 59.07M | -6.99M | -48.62M |
| 2018 | -36.02M | -2.16M | 20.36M |
| 2019 | 12.72M | -1.86M | -10.90M |
| 2020 | -3.18M | -23.13M | 51.75M |
| 2021 | -1.3M | -727K | 15.93M |
| 2022 | 17.94M | -25.44M | 10.07M |
| 2023 | 2.17M | -104.58M | 83.23M |
NAVA.OL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 55.29M | 52.62M | 39.58M | 11.43M | 11.04M | 30.24M | 26.80M | 12.29M | 6.17M | 2.24M |
Operating activities | ||||||||||
Net income | 3.30M | 42.50M | 2.35M | -16.59M | -15.47M | 7.01M | -17.13M | -10.46M | -10.29M | 2.69M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 11.92M | 7.24M | 6.71M | 3.65M | 3.62M | 6.21M | 17.58M | 22.59M | 12.65M | 8.55M |
Stock-based compensation expense | 6.87M | 970K | 2.79M | 1.84M | 1.45M | 0 | 0 | 0 | 6.10K | 0 |
| Deferred income tax benefit | 6.87M | 970K | 2.79M | 1.84M | 1.45M | 0 | 0 | 0 | 6.10K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -4.98M | -5.25M | -9.08M | -8.67M | 16.72M | 2.54M | 19.30M | -10.26M | -3.38M | -10.05M |
Inventories | -23.75M | -17.76M | -19.93M | -9.96M | 3.60M | 6.55M | 16.64M | -16.69M | 22.75M | -27.08M |
Accounts payable | 765K | -4.95M | 3.57M | 24.81M | 12.33M | -40.66M | 16.25M | 5.60M | -194.94K | 0 |
Cash generated by operating activities | 2.17M | 17.94M | -1.3M | -3.18M | 12.72M | -36.02M | 59.07M | -14.50M | 22.62M | -10.74M |
Investing activities | ||||||||||
Purchases Of Investments | -97.99M | -23.26M | 0 | -11.25M | 0 | 0 | 0 | 0 | -23.54M | 0 |
Investments In Property Plant And Equipment | -2.19M | -2.25M | -728K | -4.99M | -721.40K | -2.16M | -7.06M | -1.67M | -782.81K | -887.54K |
Acquisitions Net | 0 | -23.26M | 0 | 0 | -1.14M | 0 | 66.84K | 0 | -23.54M | 0 |
Cash generated by investing activities | -104.58M | -25.44M | -727K | -23.13M | -1.86M | -2.16M | -6.99M | -1.67M | -24.32M | -887.54K |
Financing activities | ||||||||||
Common Stock Issued | 2.26M | 1.19M | 0 | 60.44M | 0 | 0 | 0 | 11.34M | 0 | 505K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -359K | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 90.84M | 12.14M | -19.5M | -5.25M | -9.96M | -20.36M | 0 | -13.33M | 8.50M | 0 |
Cash used in financing activities | 83.23M | 10.07M | 15.93M | 51.75M | -10.90M | 20.36M | -48.62M | 31.90M | 8.34M | 15.40M |
Net Change In Cash | -17.26M | 2.67M | 13.03M | 28.14M | 392.57K | -19.20M | 3.44M | 14.50M | 6.12M | 3.93M |
Cash at end of period | 38.03M | 55.29M | 52.62M | 39.58M | 11.43M | 11.04M | 30.24M | 26.80M | 12.29M | 6.17M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |